YF-VAX 1 dose vials
Ended Awarded Last action
- Contract number
- SPE2DR26FSPG3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,114
Award facts
- Contract value 100% obligated
- $1,113.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc. for YF-VAX (yellow fever vaccine) dose vials on December 4, 2025. This firm fixed-price delivery order, with an ultimate completion date of December 26, 2025, represents a routine pharmaceutical procurement under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency. The award carries no set-aside designation, indicating competitive procurement from an unrestricted vendor pool. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, serves as a critical supplier within the federal pharmaceutical supply chain.
This delivery order falls under the broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion Defense Logistics Agency acquisition strategy. DMS Pharmaceutical Group holds a single-award IDC (contract SPE2DR) valued at $499.999 billion with a completion date of December 31, 2036, positioning the company as one of multiple regional prime vendor contractors authorized to supply comprehensive pharmaceutical products to Department of Defense military healthcare facilities worldwide. The company's extensive product portfolio and demonstrated performance on numerous prior delivery orders underscore its capability to fulfill specialized pharmaceutical requirements for federal military medical operations.
Quick answers
Who was awarded contract SPE2DR26FSPG3?
SPE2DR26FSPG3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 4, 2025.
How much is contract SPE2DR26FSPG3 worth?
The government has obligated $1,114 on SPE2DR26FSPG3.
Is contract SPE2DR26FSPG3 an order under another contract?
Yes. SPE2DR26FSPG3 is a delivery order under SPE2DR25D9337, an indefinite delivery contract.
Was contract SPE2DR26FSPG3 competed?
The extent of competition for SPE2DR26FSPG3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award